Q1. What is the business of Rodec Pharma Limited?

It manufactures vet pharmaceuticals and animal feed supplements, serving livestock healthcare and nutrition needs across India.

Q2. Why is the company raising funds via IPO?

Rodec Pharma is raising funds via IPO to offer promoter-held shares to the public and gain listing benefits like visibility, liquidity, and future capital access.

Q3. What is the size of the issue and where will it list?

The issue size of the IPO is ~56.50 lakh shares entirely as offer-for-sale. It will be listed on the BSE & NSE platform.

Q4. What are the risks to an investor?

Risk factors include dependence on livestock demand cycles, regulatory/price controls, and limited fresh funds backing growth.

Q5. What are the potential upsides?

Upsides include strong niche focus in animal healthcare with a growing distribution footprint across many Indian states.

Q6. How to apply for the IPO?

You can apply for the IPO via ASBA through bank net banking, UPI on trading apps, or through your broker within the IPO subscription window once announced.

Q 7. When is the tentative listing date?

Expected listing date is yet to be announced.

Rodec Pharma Limited IPO: GMP today, Price, Review, Detail

Upcoming

Rodec Pharma Limited IPO: GMP today, Price, Review, Detail

Market Cap

₹ 1,497 – 1,798 Crore

IPO Issue Size

56.50 lakh equity shares

Expected Price by IPOCorner

₹ 663-796

IPO Score

*Score varies on actual price

Rodec Pharma Limited is a veterinary healthcare and animal nutrition company engaged in the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs and feed supplements designed to address the healthcare and nutritional requirements of livestock animals, veterinarians, and animal healthcare providers.

Rodec Pharma Limited was incorporated in 1997 & currently Mr. Mukesh Kumar Gupta serves as the Managing Director of the company.

Rodec Pharma Limited filed its DRHP with SEBI on January 11, 2026 & the IPO features entirely as an Offer for Sale of up to 56.50 lakh equity shares.

It offers veterinary pharmaceuticals and animal nutrition solutions including antibiotics, analgesics, anthelmintics, hormones, and feed supplements for livestock health. It operates through consignee agents, 400+ stockists and 400+ sales representatives across 15+ Indian states, serving veterinarians and livestock farmers nationwide.

Subscription date to apply for Rodec Pharma Limited is yet to be announced. Price band for the IPO is yet to be declared.

56.50 lakh equity shares

Fresh Issue

N/A

Offer for Sale

56.50 lakh equity shares

Year	2025
Networth	₹ 50.03 Cr
Revenue	₹ 106.39 Cr
EBITDA	₹ 25.76 Cr
PAT	₹ 18.25 Cr
EBITDA Margin	24.21%
PAT Margin	17.16%
Face Value	Rs.10 per Equity Share

IPO Important Dates

#	Date
Open Date	TBA
Close Date	TBA
Anchor Investor Bidding	TBA
Allotment Date	TBA
Refunds& Demat Credit	TBA
Tentative Listing Date	TBA

Use Of Proceeds

Purpose	Amount
-	-
-	-
-	-
-	-
-	-
General Corporate Purpose	NA (Entirely OFS)

Financial Data

#	2023	2024	2025
Revenue (₹ Cr)	₹ 71.6	₹ 88.4	₹ 106.4
PAT (₹ Cr)	₹ 5.2	₹ 11.0	₹ 18.3
Asset (₹ Cr)	₹ 44.1	₹ 50.6	₹ 72.0
Net Worth (₹ Cr)	₹ 20.7	₹ 31.7	₹ 50.0

IPO Grey Market Premium

Date	IPO Price	IPO GMP	Profit Per Lot
08-Aug	₹ –	₹ –	₹ –
07-Aug	₹ –	₹ –	₹ –
06-Aug	₹ –	₹ –	₹ –
05-Aug	₹ –	₹ –	₹ –
04-Aug	₹ –	₹ –	₹ –

Pros

Operates in the growing animal healthcare & livestock nutrition sector.
Experienced promoter & management with decades in veterinary pharma.
Wide distribution network across multiple Indian states.
Diverse product portfolio covering pharma drugs and feed supplements.
Increasing focus on animal health and dairy productivity in India.

Cons

IPO is 100% Offer for Sale (OFS) with no fresh funds for business growth.
No disclosed market share, making competitive positioning unclear.
Business is highly dependent on livestock industry cycles.
Limited brand visibility compared to large veterinary pharma peers.
Revenue may be impacted by regulatory and pricing controls in animal healthcare.

Promoters – Pre offer equity (Approx)

Promoters	% Shares
Mukesh Kumar Gupta	51.38%
Chhaya Gupta	25.19%
Utkarsh Gupta	13.61%
-	-
-	-
-	-

Lot Size details

Application Type	Lot Size	No. of Lot	No. of Shares	Investment Amount
Retail (Min)	–	1	–	₹ –
Retail (Max)	–	13	–	₹ –
HNI (Min)	–	14	–	₹ –
HNI (Max)	–	66	–	₹ –
Big HNI (Min)	–	67	–	₹ –

Key Performance Index (KPI)

ROE	36.49%
ROCE	40.94%
RoNW	36.49%

Lead / Book Running Lead Managers

Khambatta Securities Limited

Registrar (RTA)

Bigshare Services Private Limited

Q1. What is the business of Rodec Pharma Limited?
It manufactures vet pharmaceuticals and animal feed supplements, serving livestock healthcare and nutrition needs across India.
Q2. Why is the company raising funds via IPO?
Rodec Pharma is raising funds via IPO to offer promoter-held shares to the public and gain listing benefits like visibility, liquidity, and future capital access.
Q3. What is the size of the issue and where will it list?
The issue size of the IPO is ~56.50 lakh shares entirely as offer-for-sale. It will be listed on the BSE & NSE platform.
Q4. What are the risks to an investor?
Risk factors include dependence on livestock demand cycles, regulatory/price controls, and limited fresh funds backing growth.
Q5. What are the potential upsides?
Upsides include strong niche focus in animal healthcare with a growing distribution footprint across many Indian states.
Q6. How to apply for the IPO?
You can apply for the IPO via ASBA through bank net banking, UPI on trading apps, or through your broker within the IPO subscription window once announced.
Q 7. When is the tentative listing date?
Expected listing date is yet to be announced.